120 related articles for article (PubMed ID: 17384270)
1. Insulin-like growth factor-I receptor correlates with connexin 26 and Bcl-xL expression in human colorectal cancer.
Sulkowski S; Kanczuga-Koda L; Koda M; Wincewicz A; Sulkowska M
Ann N Y Acad Sci; 2006 Dec; 1090():265-75. PubMed ID: 17384270
[TBL] [Abstract][Full Text] [Related]
2. Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer.
Kanczuga-Koda L; Sulkowski S; Koda M; Skrzydlewska E; Sulkowska M
World J Gastroenterol; 2005 Mar; 11(10):1544-8. PubMed ID: 15770735
[TBL] [Abstract][Full Text] [Related]
3. Expression of the insulin-like growth factor-I receptor and proapoptotic Bax and Bak proteins in human colorectal cancer.
Koda M; Reszec J; Sulkowska M; Kanczuga-Koda L; Sulkowski S
Ann N Y Acad Sci; 2004 Dec; 1030():377-83. PubMed ID: 15659820
[TBL] [Abstract][Full Text] [Related]
4. Alterations in connexin26 expression during colorectal carcinogenesis.
Kanczuga-Koda L; Sulkowski S; Koda M; Sulkowska M
Oncology; 2005; 68(2-3):217-22. PubMed ID: 16015037
[TBL] [Abstract][Full Text] [Related]
5. Eventual proapoptotic or anti-apoptotic impact of aberrantly expressed Cx43 and Cx26 can depend on ER-alpha overexpression in human endometrioid adenocarcinoma.
Sulkowska U; Wincewicz A; Kanczuga-Koda L; Koda M; Sulkowski S
Gynecol Endocrinol; 2015; 31(8):604-8. PubMed ID: 26299454
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor-I receptor in human oral cancer.
Reszeć J; Duraj E; Koda M; Musiatowicz B; Sulkowska M
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():58-60. PubMed ID: 15638375
[TBL] [Abstract][Full Text] [Related]
7. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
8. Expression of insulin-like growth factor-I receptor, estrogen receptor alpha, Bcl-2 and Bax proteins in human breast cancer.
Koda M; Przystupa W; Jarzabek K; Wincewicz A; Kanczuga-Koda L; Tomaszewski J; Sulkowska M; Wolczynski S; Sulkowski S
Oncol Rep; 2005 Jul; 14(1):93-8. PubMed ID: 15944774
[TBL] [Abstract][Full Text] [Related]
9. Significant coexpression of GLUT-1, Bcl-xL, and Bax in colorectal cancer.
Wincewicz A; Sulkowska M; Koda M; Kanczuga-Koda L; Witkowska E; Sulkowski S
Ann N Y Acad Sci; 2007 Jan; 1095():53-61. PubMed ID: 17404017
[TBL] [Abstract][Full Text] [Related]
10. Transforming growth factor-beta1 and regulators of apoptosis.
Sulkowski S; Wincewicz A; Sulkowska M; Koda M
Ann N Y Acad Sci; 2009 Aug; 1171():116-23. PubMed ID: 19723045
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the insulin-like growth factor I receptor in human colon carcinomas.
Weber MM; Fottner C; Liu SB; Jung MC; Engelhardt D; Baretton GB
Cancer; 2002 Nov; 95(10):2086-95. PubMed ID: 12412161
[TBL] [Abstract][Full Text] [Related]
12. Cumulative expression of HIF-1-alpha, Bax, Bcl-xL and P53 in human colorectal cancer.
Wincewicz A; Sulkowska M; Koda M; Sulkowski S
Pathology; 2007 Jun; 39(3):334-8. PubMed ID: 17558861
[TBL] [Abstract][Full Text] [Related]
13. Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein in breast cancer.
Kanczuga-Koda L; Sulkowski S; Tomaszewski J; Koda M; Sulkowska M; Przystupa W; Golaszewska J; Baltaziak M
Oncol Rep; 2005 Aug; 14(2):325-9. PubMed ID: 16012710
[TBL] [Abstract][Full Text] [Related]
14. Higher Expression of Proteins in IGF/IR Axes in Colorectal Cancer is Associated with Type 2 Diabetes Mellitus.
Ding J; Li C; Tang J; Yi C; Liu JY; Qiu M
Pathol Oncol Res; 2016 Oct; 22(4):773-9. PubMed ID: 27138191
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of the expression of connexin26 in colorectal cancer.
Nomura S; Maeda K; Noda E; Inoue T; Fukunaga S; Nagahara H; Hirakawa K
J Exp Clin Cancer Res; 2010 Jun; 29(1):79. PubMed ID: 20565955
[TBL] [Abstract][Full Text] [Related]
16. Insulin receptor substrate 1 may play divergent roles in human colorectal cancer development and progression.
Lomperta K; Jakubowska K; Grudzinska M; Kanczuga-Koda L; Wincewicz A; Surmacz E; Sulkowski S; Koda M
World J Gastroenterol; 2020 Jul; 26(28):4140-4150. PubMed ID: 32821075
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells.
Zhang Y; Zhang Y
Cancer Invest; 2008; 26(3):230-6. PubMed ID: 18317963
[TBL] [Abstract][Full Text] [Related]
18. A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo.
Ji QS; Mulvihill MJ; Rosenfeld-Franklin M; Cooke A; Feng L; Mak G; O'Connor M; Yao Y; Pirritt C; Buck E; Eyzaguirre A; Arnold LD; Gibson NW; Pachter JA
Mol Cancer Ther; 2007 Aug; 6(8):2158-67. PubMed ID: 17671083
[TBL] [Abstract][Full Text] [Related]
19. Modification of insulin-like growth factor 1 receptor, c-Src, and Bcl-XL protein expression during the progression of Barrett's neoplasia.
Iravani S; Zhang HQ; Yuan ZQ; Cheng JQ; Karl RC; Jove R; Coppola D
Hum Pathol; 2003 Oct; 34(10):975-82. PubMed ID: 14608530
[TBL] [Abstract][Full Text] [Related]
20. Dual silencing of insulin-like growth factor-I receptor and epidermal growth factor receptor in colorectal cancer cells is associated with decreased proliferation and enhanced apoptosis.
Kaulfuss S; Burfeind P; Gaedcke J; Scharf JG
Mol Cancer Ther; 2009 Apr; 8(4):821-33. PubMed ID: 19372555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
